At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
FMD WKdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessing the Efficacy and Safety of the AcusMu Microneedle Patch in Treating Periorbital Wrinkles and Skin Diseases
In Brief
An observational study evaluating FMD WK for Wrinkle. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The core objective of this study is to validate the safe and efficacious application of the AcusMu microneedle patch (FMD WK) to enhance the appearance of periorbital wrinkle
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsWrinkle
CountriesTaiwan
CollaboratorsTaipei Medical University Hospital
Timeline
N/ACompletedFinished
202420252026
Enrollment StartNov 2023
First PostedDec 2023
Primary CompletionJan 2024
Study CompletionJan 2024
TodayJul 2026
First PostedDec 6, 2023
Enrollment StartNov 24, 2023
Primary CompletionJan 26, 2024
Study CompletionJan 31, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.6 years ago
Interventions
FMD WKdevice
micro-needle patches containing active anti-wrinkle ingredients